Microsoft powerpoint - 3dg2
1. JMOL shows initially generated structure. You can
have better structure by clicking “Minimize Molecules”. But it requires your patient to see the re
2. “Save file” saves initially generated structure in
mol2 format. To save minimized structure,
“Show->Extract MOL data” option in JMOL.
1 3D structures without any spoiled fragments 2 which has all correct chiral centers3 Chirality error among plausible 3D structures generated4 after geometry optimization using MM2 force field (Chemscript module)
C[C@@]1(O)C[C@@]23C[C@@H](O)[C@]4(O)[C@H](C[C@@H](O)C4(C)C)[C@](C)(O)[C@H]2CC[C@H]1[C@H]3O GrayanotoxinIII
CC(=C)[C@H]1O[C@H]2CC[C@@]3(C)[C@@](O)(CC[C@H]4[C@H]5OC(C)(C)[C@@H]6C[C@@H]7C(=C)Cc8c(Cl)cc9[nH]c(c5c9c8[C@@]67O)[C@]34C)[C@]32O[C@@H]3[C@@H]1O PenitremA
C[C@]1(CO)[C@H](O)CC[C@]2(C)[C@H]1CC[C@@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO Aphidicolin
COc1ccc(cc1OC)C(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(O)C[C@@H](O)[C@]6(O)[C@@H](CN7C[C@H](C)CC[C@H]7[C@@]6(C)O)[C@@]5(O)C[C@@]24O[C@]13O VERATRIDINE
C[C@@H]1CCC[C@H](O)C=CC(=O)O[C@]23[C@@H](C=CC1)[C@@H](O)C(=C)[C@@H](C)[C@H]2[C@@H](Cc1ccccc1)NC3=O cytochalasinD
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c2cc3c(cc2OC)N(C)[C@@H]2[C@](O)([C@H](C(=O)OC)[C@@]4(CC)C=CCN5CC[C@@]32[C@@H]45)C(=O)OC)C1 vinblastine
CC(C)[C@@]1(O)[C@@H](OC(=O)c2ccc[nH]2)[C@@]2(O)[C@@]3(C)C[C@@]4(O)O[C@]5([C@@H](O)[C@H](C)CC[C@]35O)[C@]2(O)[C@@]14C RYANODINE
C1CCC(CC1)\N=C(/[NH+]C1C2CC3CC(C2)CC1C3)N1CCOCC1 U-37883A
CCN1C[C@@]2(COC)[C@H](O)C[C@H](OC)[C@]34[C@@H]5C[C@@]6(O)[C@@H](OC)[C@@H](O)[C@@](OC(=O)C)([C@@H]5[C@H]6OC(=O)c5ccccc5)[C@@H]([C@@H](OC)[C@H]23)[C@@H]14 aconitine
CC[C@@]12CCCN3CCc4c([C@H]13)n(c1ccccc41)[C@@](O)(C2)C(=O)OC vincamine
Oc1ccc2C[C@@H]3N(CC[C@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC=C naloxone
COc1ccc2C[C@H]3[C@H]4CCCC[C@]4(CCN3C)c2c1 dextromethorphan
CC(C)CC(=O)O[C@H]1[C@H](O[C@@H]2C[C@@H]([C@H]3CC[C@]45C[C@H](CC[C@@H]4[C@@]3(C)C2)C(=C)[C@H]5O)C(=O)O)O[C@H](CO)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-] atractyloside
O[C@H]1CC[C@]2(O)[C@H]3Cc4ccc(O)c5O[C@H]1[C@@]2(CCN3CC1CCC1)c45 nalbuphine
CC[C@@]12CCCN3CCc4c([C@H]13)n(C(=O)C2)c1ccccc41 eburnamonine
CO[C@@H]1C[C@H](O[C@H](C)[C@@H]1O)O[C@@H]1[C@@H](C)C=CC=C2CO[C@H]3CC(=C[CH](C(=O)O[CH]4C[C@@H](CC=C1C)O[C]1(CC[CH](C)[C@@H](O1)C1CCCCC1)C4)[C]23O)C selamectin
O=C1C[C@@H]2OCC=C3CN4CC[C@]56[C@@H]4C[C@H]3[C@H]2[C@@H]5N1c1ccccc61 strychnine
Oc1ccc2C[C@@H]3N(CC[C@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC1CC1 naltrexone
CC[C@H]1[C@@H](O)N2[C@H]3C[C@H]1[C@H]1[C@H](O)[C@@]4(C[C@H]21)[C@@H]3N(C)c1ccccc41 ajmaline
COc1ccc2CN(C)CC[C@]34C=C[C@@H](O)C[C@H]3Oc1c24 galanthamine
CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@@H]3O[C@@]43C(=O)O[C@@H]2[C@]14C picrotoxinin
C[C@H]1CC[C@@H]2[C@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]23OO4 artemisinin
CC[C@H](C)[C@H]1O[C@@]2(C[C@H]3C[C@@H](CC=C(C)[C@H](O[C@H]4C[C@@H](OC)[C@@H](O[C@@H]5C[C@@H](OC)[C@@H](O)[C@@H](C)O5)[C@@H](C)O4)[C@@H](C)C=CC=C4CO[C@H]5[C@@H](O)C(=C[CH](C(=O)O3)[C]45O)C)O2)C=C[C@@H]1C avermectinB1
COC1=C[C@H](C)[C@@H]2C[C@H]3OC(=O)C[C@H]4C(=C(OC)C(=O)[CH]([C]34C)[C@@]2(C)C1=O)C quassin
CC[C@H](C)C(=O)O[C@@H]1[C@H](O)[C@H]2[C@H](CN3C[C@H](C)CC[C@@H]3[C@]2(C)O)[C@H]2C[C@]34O[C@@]5(O)[C@H](CC[C@@]3(C)[C@H]5[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@H]4[C@@]12O)OC(=O)[C@@](C)(O)[C@@H](C)O protoveratrineB
CC(C)(O)[C@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@@H]3O[C@@]43C(=O)O[C@@H]2[C@]14C picrotin
CC[C@@H](C)C(=O)O[C@@H]1[C@H](O)[C@H]2[C@H](CN3C[C@H](C)CC[C@@H]3[C@]2(C)O)[C@H]2C[C@]34O[C@@]
C\C=C(/C)C(=O)O[C@@H]1CC[C@]2(C)[C@H]3CC[C@H]4[C@@]5(O)C[C@@H](O)[C@]6(O)[C@@H](CN7C[C@H](C)CC[C@@H]7[C@@]6(C)O)[C@@]5(O)C[C@@]24O[C@]13O veratrine
COC(=O)[C@]1(O)OC[C@]23[C@@H](C[C@H](OC(=O)C)[C@]4(CO[C@@H]([C@H](O)[C@@](C)([C@@H]12)[C@@]12O[C@]1(C)[C@H]1C[C@@H]2O[C@@H]2OC=C[C@@]12O)[C@H]34)C(=O)OC)OC(=O)/C(=C/C)C azadirachtin
C[C@@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@@](C)(O)[C@]1(C)O)[C@H]23 monocrotaline
CO[C@@]12CC[C@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@@H]1Cc4ccc(O)c5O[C@@H]2[C@@]3(CCN1CC1CC1)c45 buprenorphine
COc1ccc2C[C@@H]3[C@H]4C=C[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C codeine
CN1CC[C@]23[C@H]4CCC(=O)[C@@H]2Oc2c(O)ccc(C[C@@H]14)c32 hydromorphone
CN1CC[C@]23[C@@H]4Oc5c(O)ccc(C[C@@H]1[C@H]2C=C[C@@H]4O)c35 morphine
C\C(=C/CC[C]1(C)Oc2c(C\C=C(/C)C)c3O[C]45[CH]6C[C@H](C=C4C(=O)c3c(O)c2C=C1)C(=O)[C]5(C\C=C(/C)C(=O)O)OC6(C)C)C gambogicacid
CC(=O)O[C@@H]1C[C@@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)c1ccoc1 gedunin
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@@](O)([C@@H](OC(=O)C)[C@@]3(CC)C=CCN4CC[C@@]21[C@@H]34)C(=O)OC vinorelbine
Oc1ccc2C[C@H]3N(CC[C@@]4(CCCC[C@@]34O)c2c1)CC1CCC1 butorphanol
C[C@]12CCc3occc3[C@H]1CC[C@@]13C[C@H](CC[C@H]21)[C@@](O)(CO)C3 cafestol
CC(C)c1cc2[C@@H]3C[C@H]4C(C)(C)CCC[C@]4(C(=O)O3)c2c(O)c1O carnosol
C[C@@H]1CCC[C@H](O)C=CC(=O)O[C@]23[C@H]([C@@H](C)C(=C)C(=O)[C@@H]2C=CC1)[C@H](Cc1ccccc1)NC3=O cytochalasina
C[C@@H]1CC=C[C@@H]2[C@H]3O[C@@]3(C)[C@@H](C)[C@H]3[C@@H](Cc4ccccc4)NC(=O)[C@]23OC(=O)OC=C[C@](C)(O)C1=O cytochalasine
CN1C(=O)[C@@]23CC4=CC=C[C@H](O)[C@@H]4N2C(=O)[C@@]1(CO)SS3 gliotoxin
COC(=O)C[C@@](O)(CCC(C)(C)O)C(=O)O[C@@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC harringtonine
COC(=O)C[C@@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC homoharringtonine
C[C@@H]1C[C@@H]2[C@H]([C@@H]3C=C(CO)[C@H](O)[C@]4(O)[C@@H](O)C(=C[C]14C3=O)C)C2(C)C ingenol
CC1(C)CC[C@@H](O)[C@]2(CO)[C@@H]1C[C@@H](O)[C@]13[C@H](O)[C@@H](CC[C@@H]21)C(=C)C3=O kamebakaurin
CCN1C[C@]2(CC[C@@H](OC)[C@]34[C@H]2C[C@H]([C@@H]13)[C@@]1(O)C[C@@H](OC)[C@H]2C[C@@H]4[C@@]1(O)[C@@H]2OC
O[C@H]1C=C2CCN3Cc4cc5OCOc5cc4[C@H]([C@H]1O)[C@@H]23 lycorine
CCN1C[C@@]2(CC[C@H](OC)[C@@]34[C@H]5C[C@H]6[C@@H](C[C@](O)([C@H]5[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14)OC)OC(=O)c1ccccc1N1C(=O)C[C@@H](C)C1=O methyllylcaconitine
C[C@@H]1[C@@H](OC(=O)/C=C\C=C/c2ccccc2)[C@]2(O[C@@]3(O[C@H]2[C@H]2[C@@H]4O[C@@]4(CO)[C@H](O)[C@]4(O)[C@H](C=C(C)C4=O)[C@@]12O3)c1ccccc1)C(=C)C mezerein
C[C@@H]1[C@@H](OC(=O)/C=C\c2ccccc2)[C@]2(O[C@@]3(O[C@H]2[C@H]2[C@@H]4O[C@@]4(CO)[C@H](O)[C@]4(O)[C@H](C=C(C)C4=O)[C@@]12O3)c1ccccc1)C(=C)C thymeleatoxin
C[C@H]1C[C@@]2(O[C@@]3(Cc4ccccc4)O[C@@H]2[C@H]2C=C(COC(=O)Cc4ccc(O)cc4)C[C@@]4(O)[C@@H](C=C(C)C4=O)[C@@]12O3)C(=C)C tinyatoxin
CC(C)[C@@]12O[C@@H]1[C@@H]1O[C@@]31[C@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@H]1O[C@@]31[C@H]2O triptolide
COc1ccc2[C@H]3[C@@H](O)[C@]4(O)N([C@H]5CC(C)(C)OO[C@H](\C=C(/C)C)N([C@@H]35)c2c1)C(=O)[C@H]1CCCN1C4=O verruculogen
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(CC(=O)OC)c2cc3c(cc2OC)N(C=O)[C@@H]2[C@@](O)([C@H](OC(=O)C)[C@@]4(CC)C=CCN5CC[C@@]32[C@@H]45)C(=O)OC)C1 vincristine
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(CC(=O)OC)c2cc3c(cc2OC)N(C)[C@@H]2[C@@](O)([C@H](O)[C@@]4(CC)C=CCN5CC[C@@]32[C@@H]45)C(=O)N)C1 vindesine
CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]23)n1c1ccccc41 vinpocetine
C1CCC[C@H]2CCCN3CC[C@@H](CCCCCC[C@H]4CCCN5CC[C@@H](CC1)O[C@H]45)O[C@H]23 xestosponginc
O[C@]12CCCCCC[C@@H]3CCN4CCC[C@@H](CCCCCC[C@H]5CCN(CCC1)[C@@H]2O5)[C@H]4O3 xestospongind
Source: http://ebio.ssu.ac.kr/3DG/3DG_result/PR_1.pdf
metoclopramide was given only if the PONV symptoms per-sisted for 15 min or longer after treatment was initiated. Ablinded observer recorded the recovery times, emetic symp-toms, rescue antiemetics, maximum nausea scores, completeresponse to study treatment, and time to achieve dischargecriteria. Postdischarge side effects, as well and patient sat-Margarita Coloma, Paul F. White, Babatunde O.
Módulo R. Saúde da Mulher (mulheres de 18 anos e mais de idade) Neste módulo, vamos fazer perguntas sobre a sua saúde, exames preventivos, história reprodutiva e planejamento familiar. R1. Quando foi a última vez que a sra fez um exame preventivo para câncer de colo do útero? 1. Menos de 1 ano atrás 2. De 1 ano a menos de 2 anos 3. De 2 anos a menos de 3 anos 4.
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |O |
P |Q |
R |S |
T |U |
V |
W |
X |
Y |Z |0-9 |